搜索临床试验以:predictive early biomarkers, albumine modifications, liver damage.
总计33310个结果
-
University of WashingtonGlaxoSmithKline; Gilead Sciences完全的
-
University Hospital, LimogesGroupe Français de Pneumologie Cancérologie (GFPC)完全的
-
James A. Haley Veterans Administration HospitalHoffmann-La Roche终止
-
Hadassah Medical OrganizationXTL Biopharmaceuticals撤销
-
Beth Israel Medical Center终止
-
Medical College of WisconsinNational Center for Research Resources (NCRR)完全的
-
University of AlbertaGlaxoSmithKline; Axcan Pharma完全的
-
Catholic University of the Sacred Heart未知
-
University Hospital, LimogesHoffmann-La Roche完全的
-
Indiana University School of MedicineUniversity of Pennsylvania; University of South Florida; Pfizer完全的
-
Kamada, Ltd.完全的
-
Abbott完全的强直性脊柱炎法国, 德国, 希腊, 意大利, 瑞士, 西班牙, 英国, 比利时, 奥地利, 荷兰, 挪威, 丹麦, 芬兰, 爱尔兰, 瑞典
-
Gruppo Italiano Malattie EMatologiche dell'Adulto完全的
-
Radboud University Medical Center未知
-
Centers for Disease Control and PreventionAlaska Native Medical Center完全的
-
Shahid Beheshti University of Medical Sciences未知
-
University Hospital BirminghamWyeth is now a wholly owned subsidiary of Pfizer未知
-
French National Agency for Research on AIDS and...Hoffmann-La Roche; InterMune完全的
-
Centre Hospitalier Universitaire de Nice终止
-
Intarcia Therapeutics完全的
-
Australasian Gastro-Intestinal Trials Group完全的
-
Zhejiang University未知
-
National Taiwan University HospitalHoffmann-La Roche未知
-
University of Thessaly未知
-
Adherex Technologies, Inc.完全的